GuruTrack
VRTX

VRTX

VERTEX PHARMACEUTICALS INC

Data as of 2026 Q1 (03-31) · 13F snapshot

Summary
VERTEX PHARMACEUTICALS INC (VRTX) is held by 9 tracked hedge-fund managers, a combined reported value of ~$659.40M; the largest are Renaissance Technologies, Ken Griffin, Ken Griffin. This quarter: 5 trimmed, 1 closed. 20 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Cooling
Gurus holding9
Congress trades20
Price$479.00vs quarter-end+7.27%
Sectors2
This quarter's moves
New0
Added0
Trimmed / sold6
Top holderRenaissance Technologies
Ken GriffinCALL—
Value $100.07M— of portfolio224,1002026 Q1
Izzy EnglanderPUT—
Value $43.27M— of portfolio96,9002026 Q1
Dan LoebAdd
Value $39.12M0.8% of portfolio700,0002012 Q3
Ken GriffinPUT—
Value $30.41M— of portfolio68,1002026 Q1
Izzy EnglanderCALL—
Value $24.38M— of portfolio54,6002026 Q1
Steven CohenCALL—
Value $7.41M— of portfolio16,6002026 Q1
Steven CohenPUT—
Value $1.61M— of portfolio3,6002026 Q1

Insider Trading

Officers · directors · Form 4

  • Amit Sachdev

    EVP Chief Patient & Ext Af Off

    Buy
    8,251 @ $0.00Traded 2026-07-21Filed 2026-07-23

  • Ourania Tatsis

    EVP, Chief Reg. & Quality Off.

    Buy
    8,251 @ $0.00Traded 2026-07-21Filed 2026-07-23

  • Bruce I Sachs

    Director

    Buy$47.5K
    100Traded 2026-07-15Filed 2026-07-17

  • Alan M Garber

    Director

    Buy$15.0K
    32Traded 2026-07-15Filed 2026-07-17

  • Duncan Mckechnie

    EVP, Chief Commercial Officer

    Sell$799.8K
    1,541 @ $519.00Traded 2026-07-02Filed 2026-07-07

  • Ourania Tatsis

    EVP, Chief Reg. & Quality Off.

    Sell$787.5K
    1,500 @ $524.99Traded 2026-07-02Filed 2026-07-07

  • Joy Liu

    EVP and Chief Legal Officer

    Sell$416.2K
    828 @ $502.71Traded 2026-07-01Filed 2026-07-06

  • Carmen Bozic

    EVP and CMO

    Sell$287.6K
    596 @ $482.50Traded 2026-06-26Filed 2026-06-30

  • Carmen Bozic

    EVP and CMO

    Sell$471.4K
    1,020 @ $462.17Traded 2026-06-18Filed 2026-06-23

  • Carmen Bozic

    EVP and CMO

    Sell$1.83M
    4,062 @ $450.00Traded 2026-06-15Filed 2026-06-17

  • Carmen Bozic

    EVP and CMO

    Sell$785.3K
    1,745 @ $450.00Traded 2026-06-05Filed 2026-06-09

  • Joy Liu

    EVP and Chief Legal Officer

    Sell$364.2K
    828 @ $439.91Traded 2026-06-01Filed 2026-06-03

  • Carmen Bozic

    EVP and CMO

    Sell$888.3K
    1,974 @ $450.00Traded 2026-05-29Filed 2026-06-02

  • Mark E. Bunnage

    EVP, Chief Scientific Officer

    Sell$15.0K
    33 @ $453.45Traded 2026-05-15Filed 2026-05-19

  • Carmen Bozic

    EVP and CMO

    Sell$614.0K
    1,354 @ $453.45Traded 2026-05-15Filed 2026-05-19

  • Carmen Bozic

    EVP and CMO

    Sell$3.14M
    6,988 @ $450.00Traded 2026-05-12Filed 2026-05-14

  • Jennifer Schneider

    Director

    Sell
    796Traded 2026-05-01Filed 2026-05-05

  • Jennifer Schneider

    Director

    Buy
    472 @ $0.00Traded 2026-05-01Filed 2026-05-05

  • Alan M Garber

    Director

    Buy
    472 @ $0.00Traded 2026-05-01Filed 2026-05-05

  • Nancy Thornberry

    Director

    Buy
    398Traded 2026-05-01Filed 2026-05-05

  • Nancy Thornberry

    Director

    Buy
    1,433 @ $424.45Traded 2026-05-01Filed 2026-05-05

  • Michel Lagarde

    Director

    Buy
    2,866 @ $424.45Traded 2026-05-01Filed 2026-05-05

  • Joy Liu

    EVP and Chief Legal Officer

    Sell$469.2K
    1,104 @ $425.02Traded 2026-05-01Filed 2026-05-05

  • Nancy Thornberry

    Director

    Sell
    398Traded 2026-05-01Filed 2026-05-05

Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.

Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.